Laurence Matthew Rosen
The Rosen Law Firm, P.A.
- Address of record
- 355 South Grand Avenue, Suite 2450, Los Angeles, CA 90071, (213) 785-2610
- Phone
- (213) 785-2610
- Fax
- Fax (213) 226-4684
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Desouvre v. Disney Worldwide Services Inc.
A proposed class action has been filed against Disney Worldwide Services Inc. in federal court. Based on the nature of suit designation, this appears to involve statutory claims, though the specific allegations cannot be determined from the caption and docket information provided.
- Filed
- March 10, 2026
- Represents
- Yanatha Desouvre
Celsius Network Fraud Class Action
A proposed class action against Celsius Network, LLC alleging fraud. The nature of suit designation suggests claims of fraudulent conduct, potentially concerning the company's financial products or services offered to consumers and investors.
- Filed
- December 31, 2025
- Represents
- Chrishan de Almeida
Proterra Inc. Securities Litigation Settlement
Proterra Inc. and its defendants are settling securities litigation brought by shareholders who claim they were harmed by alleged misconduct related to Proterra's business combination with ArcLight Clean Transition Corp. and subsequent stock sales. The defendants are paying $29 million to resolve all claims without admitting wrongdoing.
- Settlement fund
- $29M
- Claim deadline
- August 29, 2025
- Represents
- Michael Wade, Linda Wade
ImmunityBio Inc. Securities Litigation Settlement
Lead Plaintiff alleges that ImmunityBio, Inc. and its executives made false or misleading statements regarding the company's securities during the class period. The defendants have agreed to settle the litigation for $10,500,000 in cash without admitting wrongdoing.
- Settlement fund
- $10.5M
- Claim deadline
- July 7, 2025
- Represents
- Yuchang Chen
Silvergate Capital Corporation Securities Litigation Settlement
Investors alleged that Silvergate Capital Corporation violated federal securities laws by making false and misleading statements about Silvergate Bank's vetting, due diligence, and monitoring of customers. Silvergate Capital has settled the claims for $37.5 million in cash without admitting wrongdoing.
- Settlement fund
- $37.5M
- Claim deadline
- October 21, 2025
- Represents
- John Thomas
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is accused of securities violations related to the sale of common stock. Lead plaintiffs on behalf of shareholders have reached a proposed $32,000,000 settlement to resolve all claims in the action.
- Settlement fund
- $32M
- Claim deadline
- October 7, 2026
- Represents
- Dax Billcheck
Wells Fargo Securities Action Settlement
Wells Fargo allegedly made false and misleading statements about its diversity hiring initiative, the Diverse Search Requirement. The company failed to disclose that it was conducting widespread "fake" or sham interviews of diverse candidates under this policy. When The New York Times revealed this conduct on June 9, 2022, Wells Fargo shareholders suffered losses. Wells Fargo denies all allegations and admits no wrongdoing.
- Settlement fund
- $85M
- Claim deadline
- April 14, 2026
- Represents
- Dean Sienna, Charles Rogers
T-Mobile 2021 Data Breach Settlement
T-Mobile suffered a cyber-attack in August 2021 that exposed the personal information of more than 76 million customers, including full names, dates of birth, Social Security numbers, and drivers' license information of current, former, and prospective customers. T-Mobile agreed to pay $350 million to compensate class members and invest an additional $150 million in data security improvements.
- Settlement fund
- $350M
- Claim deadline
- January 23, 2023
- Represents
- Norma Savick, Mark Savick
View Inc. Securities Litigation Settlement
Investors purchased View, Inc. (formerly CF Finance Acquisition Corp. II) securities during a specified period and are now participating in a settlement. The defendants have agreed to a settlement of $11 million to resolve securities claims, though the page does not specify what defendants allegedly did wrong or whether they admit liability.
- Settlement fund
- $11M
- Claim deadline
- December 5, 2025
- Represents
- Larry Lin
Virgin Galactic Holdings Securities Settlement
Plaintiffs claim that defendants violated federal securities laws in connection with publicly traded shares of Virgin Galactic Holdings, Inc. and Social Capital Hedosophia Holdings Corp. Defendants deny all wrongdoing and deny that they violated any laws or that any member of the settlement class suffered damages.
- Settlement fund
- $8.5M
- Claim deadline
- August 13, 2026
- Represents
- Mark Kusnier, Robert Scheele, Xinqiang Cui, Raymond Ochs, Justin Carough, Jennifer Ortiz
FibroGen, Inc. Securities Litigation Settlement
FibroGen and its executives allegedly misrepresented the safety profile and Phase III trial results of its anti-anemia drug Roxadustat in filings with the FDA. Investors claim the company's stock price was artificially inflated by these false statements and declined when the truth was revealed. The defendants deny all allegations of wrongdoing.
- Settlement fund
- $28.5M
- Claim deadline
- Represents
- Brett Richard
Tricida Securities Settlement
Tricida, Inc. and defendant Gerrit Klaerner are alleged to have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The defendant denies all claims and wrongdoing. The settlement resolves these allegations without admission of liability.
- Settlement fund
- $14.3M
- Claim deadline
- October 1, 2025
- Represents
- Michael Clynes
GSX Techedu Securities Settlement
GSX Techedu and individual defendants allegedly violated the Securities Exchange Act of 1934 by making misrepresentations and omissions about the company's enrollments and revenues in public statements, artificially inflating GSX security prices. The defendants deny all allegations of wrongdoing, but agreed to settle for $9.5 million.
- Settlement fund
- $9.5M
- Claim deadline
- Represents
- Robert Angeline, YANG RENBIN, ROBERT ANGELINE
Becton, Dickinson and Company Securities Litigation Settlement
Becton, Dickinson and Company and its former CEO Thomas E. Polen allegedly violated federal securities laws by misrepresenting the nature, extent, and revenue impact of undisclosed product issues, compliance violations, and FDA scrutiny regarding BD's Alaris infusion pump system during November 2019 to February 2020. The defendants have denied all wrongdoing while agreeing to settle for $85 million.
- Settlement fund
- $85M
- Claim deadline
- June 14, 2024
- Represents
- MICHAEL KIM
Aurora Cannabis Securities Litigation
Aurora Cannabis Inc. and executives Terry Booth and Allan Cleiren were accused of violating federal securities laws by making material misrepresentations about the company's business and prospects. The defendants deny all wrongdoing, and the parties agreed to settle the case for $8.05 million in cash without the court deciding in favor of either side.
- Settlement fund
- $8.1M
- Claim deadline
- Represents
- DILIP PARMANAND, WILLIAM WILSON
Plantronics Securities Litigation Settlement
Plantronics and several of its senior officers allegedly made false and misleading statements regarding the company's sales practices, violating federal securities laws. Defendants deny the allegations and any wrongdoing. The company has agreed to pay $29.5 million to settle the case without admitting liability.
- Settlement fund
- $29.5M
- Claim deadline
- June 25, 2025
- Represents
- Fred Strelzoff
Kraft Heinz Securities Litigation Settlement
Investors alleged that Kraft Heinz, its executives, and 3G Capital made materially false or misleading statements about the company's cost-cutting measures, brand investments, Canadian retail business, financial performance, and goodwill impairment. Investors claimed the stock price was artificially inflated and declined when the truth was revealed, causing damages. Defendants deny all allegations of wrongdoing.
- Settlement fund
- $450M
- Claim deadline
- Represents
- Earl Chesson, The Chesson Limited Partnership, EARL G. CHESSON REVOCABLE TRYST U/A DTD 4/11/2017
Celgene Corporation Securities Litigation Settlement
Celgene Corporation and certain of its officers violated federal securities laws by making false and misleading statements regarding pharmaceutical drugs and drug candidates, including GED-0301, Otezla, and Ozanimod during the class period. The defendants' misconduct allegedly damaged investors who purchased Celgene common stock.
- Settlement fund
- $239M
- Claim deadline
- April 13, 2026
- Represents
- Chester County Employees' Retirement Fund
DiDi Global Inc. Securities Settlement
DiDi Global Inc. and other defendants allegedly made false and misleading statements and omissions in the Registration Statement for DiDi's June 30, 2021 Initial Public Offering and engaged in deceptive conduct. Defendants deny all allegations of wrongdoing.
- Settlement fund
- $740M
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.